Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Bionure> ?p ?o }
Showing triples 1 to 59 of
59
with 100 triples per page.
- Bionure abstract "Bionure is a drug development company founded in 2009 as a spin-off from Hospital Clinic de Barcelona-IDIBAPS and CSIC. The company, with headquarters in Menlo Park, California, is focused on the development of small molecules for the treatment of neuromyelitis optica and acute optic neuritis. Currently, Bionure is developing BN201, which has been granted orphan drug designation by the EMA and the FDA. In 2013, Bionure entered a collaborative partnership with the Myelin Repair Foundation to assess the remyelinating properties of BN201. More recently, in 2015, Bionure entered a partnership with National Multiple Sclerosis Society that will provide funding for the late-preclinical development of BN201.".
- Bionure industry Biotechnology.
- Bionure keyPerson Stephen_L._Hauser.
- Bionure thumbnail MainLogo.png?width=300.
- Bionure wikiPageExternalLink www.bionure.com.
- Bionure wikiPageID "46459320".
- Bionure wikiPageLength "2442".
- Bionure wikiPageOutDegree "21".
- Bionure wikiPageRevisionID "661398347".
- Bionure wikiPageWikiLink August_Pi_I_Sunyer_Biomedical_Research_Institute.
- Bionure wikiPageWikiLink BN201.
- Bionure wikiPageWikiLink Biotechnology.
- Bionure wikiPageWikiLink Category:Pharmaceutical_companies.
- Bionure wikiPageWikiLink Drug_development.
- Bionure wikiPageWikiLink European_Medicines_Agency.
- Bionure wikiPageWikiLink Food_and_Drug_Administration.
- Bionure wikiPageWikiLink Hospital_Clinic_de_Barcelona.
- Bionure wikiPageWikiLink Menlo_Park,_California.
- Bionure wikiPageWikiLink Myelin_Repair_Foundation.
- Bionure wikiPageWikiLink National_Multiple_Sclerosis_Society.
- Bionure wikiPageWikiLink Neuromyelitis_optica.
- Bionure wikiPageWikiLink Optic_neuritis.
- Bionure wikiPageWikiLink Orphan_drug.
- Bionure wikiPageWikiLink Remyelination.
- Bionure wikiPageWikiLink Small_molecule.
- Bionure wikiPageWikiLink Spanish_National_Research_Council.
- Bionure wikiPageWikiLink Stephen_L._Hauser.
- Bionure wikiPageWikiLink United_States.
- Bionure wikiPageWikiLink File:MainLogo.png.
- Bionure founded "2009".
- Bionure hqLocationCity Menlo_Park,_California.
- Bionure hqLocationCountry United_States.
- Bionure industry Biotechnology.
- Bionure keyPeople "Albert G. Zamora, CEO Pablo Villoslada, CSO Stephen L. Hauser, Advisory Board".
- Bionure logo File:MainLogo.png.
- Bionure name "Bionure".
- Bionure type "Private company".
- Bionure website www.bionure.com.
- Bionure wikiPageUsesTemplate Template:Infobox_company.
- Bionure subject Category:Pharmaceutical_companies.
- Bionure hypernym Company.
- Bionure type Agent.
- Bionure type Company.
- Bionure type Organisation.
- Bionure type Organization.
- Bionure type Agent.
- Bionure type SocialPerson.
- Bionure type Thing.
- Bionure type Q43229.
- Bionure comment "Bionure is a drug development company founded in 2009 as a spin-off from Hospital Clinic de Barcelona-IDIBAPS and CSIC. The company, with headquarters in Menlo Park, California, is focused on the development of small molecules for the treatment of neuromyelitis optica and acute optic neuritis. Currently, Bionure is developing BN201, which has been granted orphan drug designation by the EMA and the FDA.".
- Bionure label "Bionure".
- Bionure sameAs Q19903525.
- Bionure sameAs m.0134mgth.
- Bionure sameAs Q19903525.
- Bionure wasDerivedFrom Bionure?oldid=661398347.
- Bionure depiction MainLogo.png.
- Bionure homepage www.bionure.com.
- Bionure isPrimaryTopicOf Bionure.
- Bionure name "Bionure".